These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 7409860)
1. Activated macrophages pre-incubated in vitro enhance rather than suppress mitogen-stimulated lymphocyte transformation. Wing EJ; Remington JS Immunology; 1980 Jun; 40(2):239-46. PubMed ID: 7409860 [TBL] [Abstract][Full Text] [Related]
2. Regulation of lymphocyte activation: macrophage-dependent suppression of T lymphocyte protein synthesis. Varesio L; Holden HT J Immunol; 1980 Oct; 125(4):1694-701. PubMed ID: 6997385 [TBL] [Abstract][Full Text] [Related]
3. [The role of L-arginine and L-citrulline in activated macrophage against Toxoplasma gondii infection in vitro]. Zheng C; Lin J Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(5):326-30. PubMed ID: 12078267 [TBL] [Abstract][Full Text] [Related]
5. Changes in thymidine incorporation into tumor cells induced by supernatants of calcium-ionophore-treated macrophages incubated with tumor cells. Stern K; Lein I In Vivo; 2001; 15(1):117-24. PubMed ID: 11286122 [TBL] [Abstract][Full Text] [Related]
6. Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis. Terrazas LI; Montero D; Terrazas CA; Reyes JL; RodrÃguez-Sosa M Int J Parasitol; 2005 Nov; 35(13):1349-58. PubMed ID: 16126211 [TBL] [Abstract][Full Text] [Related]
7. Effects of conjugated dienoic derivatives of linoleic acid and beta-carotene in modulating lymphocyte and macrophage function. Chew BP; Wong TS; Shultz TD; Magnuson NS Anticancer Res; 1997; 17(2A):1099-106. PubMed ID: 9137456 [TBL] [Abstract][Full Text] [Related]
8. [Effect of IL-6 on the multiplication of Toxoplasma gondii]. Fang Y; Tan Y; Zhang Y; Li J Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(2):106-8. PubMed ID: 12563793 [TBL] [Abstract][Full Text] [Related]
9. Toxoplasma gondii partially inhibits nitric oxide production of activated murine macrophages. Seabra SH; de Souza W; DaMatta RA Exp Parasitol; 2002 Jan; 100(1):62-70. PubMed ID: 11971655 [TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive factors secreted by human amniotic epithelial cells. Li H; Niederkorn JY; Neelam S; Mayhew E; Word RA; McCulley JP; Alizadeh H Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):900-7. PubMed ID: 15728546 [TBL] [Abstract][Full Text] [Related]
11. Macrophage proliferation during a lymphocyte transformation response: a study of mouse peritoneal cells stimulated antigenically in diffusion chambers. Reikvam A J Reticuloendothel Soc; 1975 Nov; 18(5):273. PubMed ID: 1206662 [No Abstract] [Full Text] [Related]
12. Augmentation of in vitro interleukin 10 production after in vivo administration of interleukin 18 is activated macrophage-dependent and is probably not involved in the antitumor effects of interleukin 18. Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Ikegami H; Kurimoto M Anticancer Res; 1998; 18(6A):4267-74. PubMed ID: 9891477 [TBL] [Abstract][Full Text] [Related]
13. Macrophage supernatants have both stimulatory and suppressive effects on mesangial cell proliferation. Mattana J; Singhal PC J Cell Physiol; 1993 Feb; 154(2):289-93. PubMed ID: 8425909 [TBL] [Abstract][Full Text] [Related]
14. Recombinant human macrophage-colony stimulating factor suppresses the mouse mixed lymphocyte reaction. Sakurai T; Yamada M; Simamura S; Motoyoshi K Cell Immunol; 1996 Jul; 171(1):87-94. PubMed ID: 8660842 [TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons. Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627 [TBL] [Abstract][Full Text] [Related]
16. IL-13 pre-treatment of murine peritoneal macrophages increases their anti-Toxoplasma gondii activity induced by lipopolysaccharides. Authier H; Cassaing S; Bans V; Batigne P; Bessières MH; Pipy B Int J Parasitol; 2008 Mar; 38(3-4):341-52. PubMed ID: 17923133 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide production by splenic macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus. Rowland RR; Butz EA; Plagemann PG J Immunol; 1994 Jun; 152(12):5785-95. PubMed ID: 8207208 [TBL] [Abstract][Full Text] [Related]
18. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells. Yoshimoto T; Nagai N; Ohkusu K; Ueda H; Okamura H; Nakanishi K J Immunol; 1998 Aug; 161(3):1483-92. PubMed ID: 9686615 [TBL] [Abstract][Full Text] [Related]
19. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages. Sone S; Fidler IJ J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635 [TBL] [Abstract][Full Text] [Related]
20. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK]. Chang ZL; Lin MQ; Wang MZ; Yao Z Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]